These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 29379802)

  • 1. Inflammatory Cytokine Signaling during Development of Pancreatic and Prostate Cancers.
    Liou GY
    J Immunol Res; 2017; 2017():7979637. PubMed ID: 29379802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory cytokines in human pancreatic cancer.
    Roshani R; McCarthy F; Hagemann T
    Cancer Lett; 2014 Apr; 345(2):157-63. PubMed ID: 23879960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of benign prostatic hyperplasia is associated with pro-inflammatory mediators and chronic activation of prostate-infiltrating lymphocytes.
    Norström MM; Rådestad E; Sundberg B; Mattsson J; Henningsohn L; Levitsky V; Uhlin M
    Oncotarget; 2016 Apr; 7(17):23581-93. PubMed ID: 26993768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphatidylinositol 3-Kinase: A Link Between Inflammation and Pancreatic Cancer.
    Birtolo C; Go VL; Ptasznik A; Eibl G; Pandol SJ
    Pancreas; 2016 Jan; 45(1):21-31. PubMed ID: 26658038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Pancreatitis and the Development of Pancreatic Cancer.
    Kandikattu HK; Venkateshaiah SU; Mishra A
    Endocr Metab Immune Disord Drug Targets; 2020; 20(8):1182-1210. PubMed ID: 32324526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiome, inflammation and colorectal cancer.
    Chen J; Pitmon E; Wang K
    Semin Immunol; 2017 Aug; 32():43-53. PubMed ID: 28982615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory signaling and cellular senescence.
    Ren JL; Pan JS; Lu YP; Sun P; Han J
    Cell Signal; 2009 Mar; 21(3):378-83. PubMed ID: 18992324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TLR7 expression is decreased during tumour progression in transgenic adenocarcinoma of mouse prostate mice and its activation inhibits growth of prostate cancer cells.
    Han JH; Park SY; Kim JB; Cho SD; Kim B; Kim BY; Kang MJ; Kim DJ; Park JH; Park JH
    Am J Reprod Immunol; 2013 Oct; 70(4):317-26. PubMed ID: 23790156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-related alterations in T-lymphocytes modulate key pathways in prostate tumorigenesis.
    De Angulo A; Faris R; Cavazos D; Jolly C; Daniel B; DeGraffenried L
    Prostate; 2013 Jun; 73(8):855-64. PubMed ID: 23532664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-33 acts as a pro-inflammatory cytokine and modulates its receptor gene expression in highly metastatic human pancreatic carcinoma cells.
    Schmieder A; Multhoff G; Radons J
    Cytokine; 2012 Nov; 60(2):514-21. PubMed ID: 22819319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncostatin M induces tumorigenic properties in non-transformed human prostate epithelial cells, in part through activation of signal transducer and activator of transcription 3 (STAT3).
    Sterbova S; Karlsson T; Persson E
    Biochem Biophys Res Commun; 2018 Apr; 498(4):769-774. PubMed ID: 29526757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow-derived mesenchymal stem cells induced by inflammatory cytokines produce angiogenetic factors and promote prostate cancer growth.
    Yang KQ; Liu Y; Huang QH; Mo N; Zhang QY; Meng QG; Cheng JW
    BMC Cancer; 2017 Dec; 17(1):878. PubMed ID: 29268703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced prostate cancer: reinforcing the strings between inflammation and the metastatic behavior.
    Gueron G; De Siervi A; Vazquez E
    Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):213-21. PubMed ID: 22183772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of oridonin-mediated hallmark changes on inflammatory pathways in human pancreatic cancer (BxPC-3) cells.
    Chen RY; Xu B; Chen SF; Chen SS; Zhang T; Ren J; Xu J
    World J Gastroenterol; 2014 Oct; 20(40):14895-903. PubMed ID: 25356049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the mediators of inflammation in cancer development.
    Fernandes JV; Cobucci RN; Jatobá CA; Fernandes TA; de Azevedo JW; de Araújo JM
    Pathol Oncol Res; 2015 Jul; 21(3):527-34. PubMed ID: 25740073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation-mediated abrogation of androgen signaling: an in vitro model of prostate cell inflammation.
    Debelec-Butuner B; Alapinar C; Varisli L; Erbaykent-Tepedelen B; Hamid SM; Gonen-Korkmaz C; Korkmaz KS
    Mol Carcinog; 2014 Feb; 53(2):85-97. PubMed ID: 22911881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic inflammation and pathogenesis of GI and pancreatic cancers.
    Jackson L; Evers BM
    Cancer Treat Res; 2006; 130():39-65. PubMed ID: 16610702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signal integration, crosstalk mechanisms and networks in the function of inflammatory cytokines.
    Schmitz ML; Weber A; Roxlau T; Gaestel M; Kracht M
    Biochim Biophys Acta; 2011 Dec; 1813(12):2165-75. PubMed ID: 21787809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells.
    Vignozzi L; Cellai I; Santi R; Lombardelli L; Morelli A; Comeglio P; Filippi S; Logiodice F; Carini M; Nesi G; Gacci M; Piccinni MP; Adorini L; Maggi M
    J Endocrinol; 2012 Jul; 214(1):31-43. PubMed ID: 22562653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A human prostatic bacterial isolate alters the prostatic microenvironment and accelerates prostate cancer progression.
    Simons BW; Durham NM; Bruno TC; Grosso JF; Schaeffer AJ; Ross AE; Hurley PJ; Berman DM; Drake CG; Thumbikat P; Schaeffer EM
    J Pathol; 2015 Feb; 235(3):478-89. PubMed ID: 25348195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.